ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,743.50
      -0.03%
      US Tech 100
      19,492.00
      -0.44%
      Dow Jones
      42,377.50
      0.48%
      Brent Oil
      71.655
      0.99%
      Bitcoin
      65,850.08
      0.99%
      Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Daxor Corporation (DXR)

      7. Daxor Corporation (DXR) News

      DXR

      Daxor (DXR)

      Daxor Corporation
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:DXR
      DateTimeSourceHeadlineSymbolCompany
      09/19/20248:00AMGlobeNewswire Inc.Daxor Corporation to Exhibit at the Heart Failure Society of America Annual Scientific Meeting 2024NASDAQ:DXRDaxor Corporation
      09/12/20248:00AMGlobeNewswire Inc.Newly Published Review Highlights the Pivotal Role of Daxor’s Blood Volume Analysis Technology in Advancing Cardiorenal Syndrome ManagementNASDAQ:DXRDaxor Corporation
      09/05/20248:00AMGlobeNewswire Inc.Daxor Corporation Receives $300K Matching Fund Award From Launch TennesseeNASDAQ:DXRDaxor Corporation
      09/04/20248:30AMGlobeNewswire Inc.Leading Central Florida Hospital Implements Daxor’s BVA-100™ Blood Volume Diagnostic for Heart Failure Patient CareNASDAQ:DXRDaxor Corporation
      09/03/20244:05PMGlobeNewswire Inc.Daxor Corporation CEO and President Michael Feldschuh Delivers Corporate Update in Shareholder LetterNASDAQ:DXRDaxor Corporation
      09/03/202412:15PMGlobeNewswire Inc.Daxor Corporation to Present at the H.C. Wainwright 26th Annual Global Investment ConferenceNASDAQ:DXRDaxor Corporation
      08/29/20245:27PMEdgar (US Regulatory)Form NPORT-P - Monthly Portfolio Investments Report on Form N-PORT (Public)NASDAQ:DXRDaxor Corporation
      08/29/20245:16PMEdgar (US Regulatory)Form N-CSRS - Certified Shareholder Report, Semi-AnnualNASDAQ:DXRDaxor Corporation
      08/29/20248:00AMGlobeNewswire Inc.Daxor Corporation Announces Launch of BVA Program at Mid-South Largest Integrated NetworkNASDAQ:DXRDaxor Corporation
      08/23/20244:52PMEdgar (US Regulatory)Form 40-17G - Fidelity Bond [Rule 17G-1(g)]NASDAQ:DXRDaxor Corporation
      08/16/20245:23PMEdgar (US Regulatory)Form N-2 - Registration statement for closed-end investment companiesNASDAQ:DXRDaxor Corporation
      08/06/20248:00AMGlobeNewswire Inc.Daxor Corporation Awarded $1.9M Contract by The U.S. Air Force for Development of its Next Generation Tracer System in its Point-of-Care Blood Volume AnalyzerNASDAQ:DXRDaxor Corporation
      08/05/20248:00AMGlobeNewswire Inc.Daxor Expands To Three New Facilities As Blood Volume Analysis Technology Gains Momentum NationwideNASDAQ:DXRDaxor Corporation
      07/24/20248:00AMGlobeNewswire Inc.Daxor Corporation Awarded New U.S. Defense Health Agency Contract for Added Capabilities to Its Point-of-Care Blood Volume AnalyzerNASDAQ:DXRDaxor Corporation
      07/18/20242:46PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:DXRDaxor Corporation
      07/17/20246:01PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DXRDaxor Corporation
      07/17/20245:54PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DXRDaxor Corporation
      07/17/20245:50PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DXRDaxor Corporation
      07/17/20245:46PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DXRDaxor Corporation
      07/11/20248:00AMGlobeNewswire Inc.Daxor Corporation’s BVA-100™ Blood Volume Diagnostic Expands to Three New Centers, Gains Traction NationwideNASDAQ:DXRDaxor Corporation
      06/18/20248:00AMGlobeNewswire Inc.Daxor Corporation to Showcase the Benefits of BVA-100™ Guided-Care at the American Association of Heart Failure Nurses (AAHFN) 20th Annual MeetingNASDAQ:DXRDaxor Corporation
      06/05/20244:10PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:DXRDaxor Corporation
      06/05/20248:00AMGlobeNewswire Inc.Daxor Corporation Appoints John L. Jefferies, M.D. as Chief Medical OfficerNASDAQ:DXRDaxor Corporation
      05/30/20246:43AMEdgar (US Regulatory)Form NPORT-P - Monthly Portfolio Investments Report on Form N-PORT (Public)NASDAQ:DXRDaxor Corporation
      04/16/20248:00AMGlobeNewswire Inc.New Studies Prove the Clinical Benefits of Daxor’s Blood Volume (BVA-100TM) Diagnostic In Ambulatory Heart Failure Patients For Measurement of CongestionNASDAQ:DXRDaxor Corporation
      04/15/20248:00AMGlobeNewswire Inc.DAXOR CORPORATION TO EXHIBIT AT THE MEDAXIOM CARDIOVASCULAR TRANSFORUM CONFERENCE SPRING’24 TO ADVANCE AWARENESS AND FURTHER ADOPTION OF DAXOR’S BLOOD VOLUME DIAGNOSTIC (BVA-100™)NASDAQ:DXRDaxor Corporation
      04/10/20248:00AMGlobeNewswire Inc.Daxor Corporation Announces New Hospital Account at Leading Chicago HospitalNASDAQ:DXRDaxor Corporation
      04/01/20248:00AMGlobeNewswire Inc.Daxor Corporation to Exhibit at the American College of Cardiology for ACC.24NASDAQ:DXRDaxor Corporation
      03/25/20248:00AMGlobeNewswire Inc.Daxor Corporation Acquires Volumex® and Megatope® From Its Existing Supplier Along With Glofil® to Enhance Existing Suite of DiagnosticsNASDAQ:DXRDaxor Corporation
      03/22/20248:00AMGlobeNewswire Inc.Daxor Corporation to Hold Investor Call Discussing Fiscal Year 2023 Financial Results and Corporate Update on March 25, 2024NASDAQ:DXRDaxor Corporation
       Showing the most relevant articles for your search:NASDAQ:DXR